Repeatedly injecting the same small area causes lipohypertrophy, a condition where subcutaneous fat tissue thickens and hardens in response to repeated mechanical trauma and medication exposure
These not only add flavor but can also support digestion and reduce bloating
Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus treatment
Retatrutide is an investigational injectable triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors to reduce appetite, improve blood glucose control, and increase energy expenditure
First-time prescribing of AOM semaglutide decreased again this quarter (-11.75%), while prescribing of AOM tirzepatide increased (46.37%)
This is fundamentally different from prescription GLP-1 peptides that directly activate GLP-1 receptors